nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepivacaine—Respiratory arrest—Aminophylline—chronic obstructive pulmonary disease	0.0304	0.0317	CcSEcCtD
Mepivacaine—Excitement—Aminophylline—chronic obstructive pulmonary disease	0.0273	0.0285	CcSEcCtD
Mepivacaine—Respiratory arrest—Arformoterol—chronic obstructive pulmonary disease	0.0232	0.0242	CcSEcCtD
Mepivacaine—Respiratory arrest—Formoterol—chronic obstructive pulmonary disease	0.0232	0.0242	CcSEcCtD
Mepivacaine—Paraesthesia oral—Arformoterol—chronic obstructive pulmonary disease	0.0217	0.0227	CcSEcCtD
Mepivacaine—Paraesthesia oral—Formoterol—chronic obstructive pulmonary disease	0.0217	0.0227	CcSEcCtD
Mepivacaine—Excitement—Salbutamol—chronic obstructive pulmonary disease	0.0196	0.0205	CcSEcCtD
Mepivacaine—Ventricular arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.0181	0.0189	CcSEcCtD
Mepivacaine—Block heart—Formoterol—chronic obstructive pulmonary disease	0.0179	0.0187	CcSEcCtD
Mepivacaine—Block heart—Arformoterol—chronic obstructive pulmonary disease	0.0179	0.0187	CcSEcCtD
Mepivacaine—Paralysis—Arformoterol—chronic obstructive pulmonary disease	0.0147	0.0153	CcSEcCtD
Mepivacaine—Paralysis—Formoterol—chronic obstructive pulmonary disease	0.0147	0.0153	CcSEcCtD
Mepivacaine—Meningitis—Prednisolone—chronic obstructive pulmonary disease	0.0142	0.0148	CcSEcCtD
Mepivacaine—Atrioventricular block—Arformoterol—chronic obstructive pulmonary disease	0.0105	0.011	CcSEcCtD
Mepivacaine—Atrioventricular block—Formoterol—chronic obstructive pulmonary disease	0.0105	0.011	CcSEcCtD
Mepivacaine—Meningitis—Prednisone—chronic obstructive pulmonary disease	0.0103	0.0108	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Aminophylline—chronic obstructive pulmonary disease	0.01	0.0105	CcSEcCtD
Mepivacaine—Urinary retention—Aminophylline—chronic obstructive pulmonary disease	0.00924	0.00963	CcSEcCtD
Mepivacaine—Levobupivacaine—CYP1A2—chronic obstructive pulmonary disease	0.00876	0.212	CrCbGaD
Mepivacaine—Urinary retention—Tiotropium—chronic obstructive pulmonary disease	0.00871	0.00909	CcSEcCtD
Mepivacaine—Tension—Roflumilast—chronic obstructive pulmonary disease	0.00861	0.00898	CcSEcCtD
Mepivacaine—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.00852	0.00889	CcSEcCtD
Mepivacaine—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.00849	0.00885	CcSEcCtD
Mepivacaine—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00822	0.00857	CcSEcCtD
Mepivacaine—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00802	0.00836	CcSEcCtD
Mepivacaine—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.00744	0.00776	CcSEcCtD
Mepivacaine—Lidocaine—EGFR—chronic obstructive pulmonary disease	0.00743	0.18	CrCbGaD
Mepivacaine—Bupivacaine—CYP1A2—chronic obstructive pulmonary disease	0.007	0.169	CrCbGaD
Mepivacaine—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.00588	0.00613	CcSEcCtD
Mepivacaine—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00574	0.00599	CcSEcCtD
Mepivacaine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00569	0.00593	CcSEcCtD
Mepivacaine—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.00568	0.00593	CcSEcCtD
Mepivacaine—Ropivacaine—CYP1A2—chronic obstructive pulmonary disease	0.00564	0.137	CrCbGaD
Mepivacaine—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00558	0.00582	CcSEcCtD
Mepivacaine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.00548	0.00572	CcSEcCtD
Mepivacaine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00538	0.00561	CcSEcCtD
Mepivacaine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00538	0.00561	CcSEcCtD
Mepivacaine—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.00534	0.00557	CcSEcCtD
Mepivacaine—Tocainide—CYP1A2—chronic obstructive pulmonary disease	0.0053	0.128	CrCbGaD
Mepivacaine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00527	0.0055	CcSEcCtD
Mepivacaine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.0052	0.00542	CcSEcCtD
Mepivacaine—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.00516	0.00538	CcSEcCtD
Mepivacaine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00514	0.00536	CcSEcCtD
Mepivacaine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00507	0.00529	CcSEcCtD
Mepivacaine—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00504	0.00526	CcSEcCtD
Mepivacaine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00496	0.00518	CcSEcCtD
Mepivacaine—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00495	0.00516	CcSEcCtD
Mepivacaine—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00485	0.00506	CcSEcCtD
Mepivacaine—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00477	0.00498	CcSEcCtD
Mepivacaine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00476	0.00497	CcSEcCtD
Mepivacaine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00473	0.00494	CcSEcCtD
Mepivacaine—Shock—Aminophylline—chronic obstructive pulmonary disease	0.0047	0.0049	CcSEcCtD
Mepivacaine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00466	0.00486	CcSEcCtD
Mepivacaine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00455	0.00475	CcSEcCtD
Mepivacaine—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.0045	0.0047	CcSEcCtD
Mepivacaine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.0045	0.0047	CcSEcCtD
Mepivacaine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00449	0.00468	CcSEcCtD
Mepivacaine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00446	0.00465	CcSEcCtD
Mepivacaine—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00443	0.00462	CcSEcCtD
Mepivacaine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00439	0.00458	CcSEcCtD
Mepivacaine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00437	0.00456	CcSEcCtD
Mepivacaine—Tension—Formoterol—chronic obstructive pulmonary disease	0.00437	0.00456	CcSEcCtD
Mepivacaine—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00433	0.00452	CcSEcCtD
Mepivacaine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.00432	0.00451	CcSEcCtD
Mepivacaine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.00432	0.00451	CcSEcCtD
Mepivacaine—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00431	0.00449	CcSEcCtD
Mepivacaine—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00431	0.00449	CcSEcCtD
Mepivacaine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00425	0.00444	CcSEcCtD
Mepivacaine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00417	0.00435	CcSEcCtD
Mepivacaine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00417	0.00435	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.00414	0.00432	CcSEcCtD
Mepivacaine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00413	0.0043	CcSEcCtD
Mepivacaine—Lidocaine—CYP1A2—chronic obstructive pulmonary disease	0.0041	0.0993	CrCbGaD
Mepivacaine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00409	0.00427	CcSEcCtD
Mepivacaine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00409	0.00427	CcSEcCtD
Mepivacaine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00409	0.00426	CcSEcCtD
Mepivacaine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00408	0.00426	CcSEcCtD
Mepivacaine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00407	0.00424	CcSEcCtD
Mepivacaine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00407	0.00424	CcSEcCtD
Mepivacaine—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00407	0.00424	CcSEcCtD
Mepivacaine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00404	0.00422	CcSEcCtD
Mepivacaine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00401	0.00418	CcSEcCtD
Mepivacaine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00398	0.00416	CcSEcCtD
Mepivacaine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00394	0.00411	CcSEcCtD
Mepivacaine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00386	0.00403	CcSEcCtD
Mepivacaine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00384	0.00401	CcSEcCtD
Mepivacaine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00384	0.00401	CcSEcCtD
Mepivacaine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00384	0.00401	CcSEcCtD
Mepivacaine—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.00381	0.00397	CcSEcCtD
Mepivacaine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00379	0.00396	CcSEcCtD
Mepivacaine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00378	0.00394	CcSEcCtD
Mepivacaine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00378	0.00394	CcSEcCtD
Mepivacaine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00378	0.00394	CcSEcCtD
Mepivacaine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00377	0.00394	CcSEcCtD
Mepivacaine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00377	0.00393	CcSEcCtD
Mepivacaine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.0037	0.00386	CcSEcCtD
Mepivacaine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00369	0.00385	CcSEcCtD
Mepivacaine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00363	0.00379	CcSEcCtD
Mepivacaine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00363	0.00379	CcSEcCtD
Mepivacaine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00363	0.00379	CcSEcCtD
Mepivacaine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00363	0.00379	CcSEcCtD
Mepivacaine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00363	0.00379	CcSEcCtD
Mepivacaine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00358	0.00373	CcSEcCtD
Mepivacaine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00357	0.00372	CcSEcCtD
Mepivacaine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00356	0.00371	CcSEcCtD
Mepivacaine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00356	0.00371	CcSEcCtD
Mepivacaine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00355	0.0037	CcSEcCtD
Mepivacaine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00355	0.0037	CcSEcCtD
Mepivacaine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00352	0.00367	CcSEcCtD
Mepivacaine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00343	0.00358	CcSEcCtD
Mepivacaine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00343	0.00358	CcSEcCtD
Mepivacaine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.0034	0.00354	CcSEcCtD
Mepivacaine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.0034	0.00354	CcSEcCtD
Mepivacaine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00338	0.00352	CcSEcCtD
Mepivacaine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00338	0.00352	CcSEcCtD
Mepivacaine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00337	0.00352	CcSEcCtD
Mepivacaine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00335	0.00349	CcSEcCtD
Mepivacaine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00332	0.00346	CcSEcCtD
Mepivacaine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00332	0.00346	CcSEcCtD
Mepivacaine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00323	0.00337	CcSEcCtD
Mepivacaine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00323	0.00337	CcSEcCtD
Mepivacaine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00321	0.00334	CcSEcCtD
Mepivacaine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.0032	0.00333	CcSEcCtD
Mepivacaine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00319	0.00332	CcSEcCtD
Mepivacaine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00316	0.0033	CcSEcCtD
Mepivacaine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00316	0.00329	CcSEcCtD
Mepivacaine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00308	0.00321	CcSEcCtD
Mepivacaine—Tocainide—ALB—chronic obstructive pulmonary disease	0.00306	0.0742	CrCbGaD
Mepivacaine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00305	0.00318	CcSEcCtD
Mepivacaine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00304	0.00317	CcSEcCtD
Mepivacaine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00299	0.00312	CcSEcCtD
Mepivacaine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00298	0.00311	CcSEcCtD
Mepivacaine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00289	0.00301	CcSEcCtD
Mepivacaine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00289	0.00301	CcSEcCtD
Mepivacaine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00287	0.003	CcSEcCtD
Mepivacaine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00287	0.003	CcSEcCtD
Mepivacaine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00286	0.00299	CcSEcCtD
Mepivacaine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00284	0.00296	CcSEcCtD
Mepivacaine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00283	0.00295	CcSEcCtD
Mepivacaine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00282	0.00294	CcSEcCtD
Mepivacaine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.00282	0.00294	CcSEcCtD
Mepivacaine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00281	0.00293	CcSEcCtD
Mepivacaine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.00277	0.00289	CcSEcCtD
Mepivacaine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00273	0.00284	CcSEcCtD
Mepivacaine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00271	0.00283	CcSEcCtD
Mepivacaine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00268	0.00279	CcSEcCtD
Mepivacaine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00268	0.00279	CcSEcCtD
Mepivacaine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00267	0.00279	CcSEcCtD
Mepivacaine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00262	0.00274	CcSEcCtD
Mepivacaine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00261	0.00272	CcSEcCtD
Mepivacaine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00261	0.00272	CcSEcCtD
Mepivacaine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00257	0.00268	CcSEcCtD
Mepivacaine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00257	0.00268	CcSEcCtD
Mepivacaine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00255	0.00266	CcSEcCtD
Mepivacaine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00253	0.00264	CcSEcCtD
Mepivacaine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00252	0.00263	CcSEcCtD
Mepivacaine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00246	0.00257	CcSEcCtD
Mepivacaine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.00245	0.00256	CcSEcCtD
Mepivacaine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00243	0.00253	CcSEcCtD
Mepivacaine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00241	0.00252	CcSEcCtD
Mepivacaine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.0024	0.00251	CcSEcCtD
Mepivacaine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.0024	0.00251	CcSEcCtD
Mepivacaine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00235	0.00245	CcSEcCtD
Mepivacaine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00231	0.00241	CcSEcCtD
Mepivacaine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00231	0.00241	CcSEcCtD
Mepivacaine—Headache—Formoterol—chronic obstructive pulmonary disease	0.00228	0.00237	CcSEcCtD
Mepivacaine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00228	0.00237	CcSEcCtD
Mepivacaine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00227	0.00237	CcSEcCtD
Mepivacaine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00227	0.00237	CcSEcCtD
Mepivacaine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00226	0.00236	CcSEcCtD
Mepivacaine—Headache—Montelukast—chronic obstructive pulmonary disease	0.00223	0.00233	CcSEcCtD
Mepivacaine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.0022	0.0023	CcSEcCtD
Mepivacaine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00218	0.00228	CcSEcCtD
Mepivacaine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00216	0.00226	CcSEcCtD
Mepivacaine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00216	0.00225	CcSEcCtD
Mepivacaine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00216	0.00225	CcSEcCtD
Mepivacaine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00215	0.00224	CcSEcCtD
Mepivacaine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00212	0.00221	CcSEcCtD
Mepivacaine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00211	0.00221	CcSEcCtD
Mepivacaine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00209	0.00218	CcSEcCtD
Mepivacaine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00208	0.00217	CcSEcCtD
Mepivacaine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00205	0.00214	CcSEcCtD
Mepivacaine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00204	0.00213	CcSEcCtD
Mepivacaine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00197	0.00205	CcSEcCtD
Mepivacaine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00197	0.00205	CcSEcCtD
Mepivacaine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.00194	0.00202	CcSEcCtD
Mepivacaine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00192	0.002	CcSEcCtD
Mepivacaine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.0019	0.00198	CcSEcCtD
Mepivacaine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00177	0.00184	CcSEcCtD
Mepivacaine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00175	0.00183	CcSEcCtD
Mepivacaine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00165	0.00172	CcSEcCtD
Mepivacaine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00161	0.00168	CcSEcCtD
Mepivacaine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.0016	0.00167	CcSEcCtD
Mepivacaine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.00157	0.00164	CcSEcCtD
Mepivacaine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00156	0.00163	CcSEcCtD
Mepivacaine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.00154	0.00161	CcSEcCtD
Mepivacaine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00152	0.00158	CcSEcCtD
Mepivacaine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.00151	0.00158	CcSEcCtD
Mepivacaine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.00149	0.00155	CcSEcCtD
Mepivacaine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00145	0.00151	CcSEcCtD
Mepivacaine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00143	0.00149	CcSEcCtD
Mepivacaine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.00143	0.00149	CcSEcCtD
Mepivacaine—Shock—Prednisone—chronic obstructive pulmonary disease	0.00141	0.00147	CcSEcCtD
Mepivacaine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.0014	0.00146	CcSEcCtD
Mepivacaine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.00138	0.00144	CcSEcCtD
Mepivacaine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.0013	0.00136	CcSEcCtD
Mepivacaine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.00128	0.00134	CcSEcCtD
Mepivacaine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00123	0.00129	CcSEcCtD
Mepivacaine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00117	0.00122	CcSEcCtD
Mepivacaine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00114	0.00118	CcSEcCtD
Mepivacaine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00113	0.00118	CcSEcCtD
Mepivacaine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00105	0.0011	CcSEcCtD
Mepivacaine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00103	0.00107	CcSEcCtD
Mepivacaine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00101	0.00106	CcSEcCtD
Mepivacaine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000946	0.000986	CcSEcCtD
Mepivacaine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000909	0.000948	CcSEcCtD
Mepivacaine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000896	0.000934	CcSEcCtD
Mepivacaine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000849	0.000886	CcSEcCtD
